Illumina Shares Fall 8 Percent After Roche Nixes Acquisition Rumors
January 07, 2013
Illumina Shares Fall 8 Percent After Roche Nixes Acquisition Rumors
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Roche Raises Bid to Acquire Illumina to $6.7B
March 29, 2012 / GenomeWeb Daily News - Sequenom's CEO 'Puzzled' by Illumina's Buy of Verinata, Lays out 2013 Goals at JP Morgan
January 10, 2013 / GenomeWeb Daily News - Following Verinata Acquisition, Illumina Plans to Submit Prenatal Test to FDA as IVD Product
January 9, 2013 / Clinical Sequencing News - Illumina Acquires Moleculo, Plans to Increase MiSeq Reads to 400 Bases, Opens New Sequencing Facility
January 8, 2013 / In Sequence - Illumina to Acquire Verinata for up to $450M
January 7, 2013 / GenomeWeb Daily News